Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients

Bibliographic Details
Main Authors:	Paul J. Hengeveld, Joyce Schilperoord-Vermeulen, P. Martijn Kolijn, Julie M. N. Dubois, Peter E. Westerweel, Sabina Kersting, Arnon P. Kater, Mark-David Levin, Anton W. Langerak
Format:	Article
Language:	English
Published:	Nature Publishing Group 2025-01-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-025-01209-9

Internet